Cyto-reductive Surgery combined with Hyperthermic Intra-Peritoneal Chemotherapy for Peritoneal Surface Malignancies: Current treatment and results

Cancer Treatment Reviews

Volumn 38, Issue 4, 2012, Pages 258-268

  Sommariva, Antonio ^a   Pilati, Pierluigi ^b   Rossi, Carlo Riccardo ^a,b  

^a VENETO INSTITUTE OF ONCOLOGY IOV IRCCS   (Italy)

^b UNIVERSITY OF PADOVA   (Italy)

Author keywords

Chemo hyperthermia; Cytoreductive surgery; Peritoneal carcinomatosis

Indexed keywords

CARBOPLATIN; CISPLATIN; DOCETAXEL; DOXORUBICIN; ETOPOSIDE; FLUORODEOXYGLUCOSE; FLUOROURACIL; FOLINIC ACID; IRINOTECAN; MELPHALAN; MITOMYCIN C; MITOXANTRONE; OXALIPLATIN; PACLITAXEL;

ABDOMINAL SARCOMATOSIS; APPENDIX CANCER; CANCER CHEMOTHERAPY; CANCER MORTALITY; CARCINOMATOUS PERITONITIS; COLON CANCER; COLORECTAL CANCER; CYTOREDUCTIVE SURGERY; DRUG DOSE ESCALATION; HUMAN; HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY; HYPERTHERMIC THERAPY; LAPAROSCOPIC SURGERY; LAPAROTOMY; MESOTHELIOMA; OVARY CANCER; PERITONEUM CANCER; PERITONEUM PSEUDOMYXOMA; POSITRON EMISSION TOMOGRAPHY; PREOPERATIVE EVALUATION; REVIEW; SARCOMATOSIS; STOMACH CANCER; SURVIVAL TIME; TREATMENT INDICATION; TREATMENT OUTCOME;

ANTINEOPLASTIC AGENTS; COMBINED MODALITY THERAPY; HUMANS; HYPERTHERMIA, INDUCED; PERITONEAL NEOPLASMS;

EID: 84859159911     PISSN: 03057372     EISSN: 15321967     Source Type: Journal    
DOI: 10.1016/j.ctrv.2011.07.001     Document Type: Review

References (173)

1. Chu D.Z., Lang N.P., Thompson C., et al. Peritoneal carcinomatosis in nongynecologic malignancy. A prospective study of prognostic factors. Cancer 1989, 63:364-367.
2. Sadeghi B., Arvieux C., Glehen O., et al. Peritoneal carcinomatosis from non-gynecologic malignancies: results of the EVOCAPE 1 multicentric prospective study. Cancer 2000, 88:358-363.
3. Jayne D.G., Fook S., Loi C., et al. Peritoneal carcinomatosis from colorectal cancer. Br J Surg 2002, 89:1545-1550.
4. Weiss L. Metastatic inefficiency: intravascular and intraperitoneal implantation of cancer cells. Cancer Treat Res 1996, 82:1-11.
5. Carmignani C.P., Sugarbaker T.A., Bromley C.M., et al. Intraperitoneal cancer dissemination: mechanisms of the patterns of spread. Cancer Metastasis Rev 2003, 22:465-472.
6. Sugarbaker P.H. New standard of care for appendiceal epithelial neoplasms and pseudomyxoma peritonei syndrome?. Lancet Oncol 2006, 7(1):69-76.
7. Yan T.D., Welch L., Black D., et al. A systematic review on the efficacy of cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for diffuse malignancy peritoneal mesothelioma. Ann Oncol 2007, 18:827-834.
8. Cao C., Yan T.D., Black D., et al. A systematic review and meta-analysis of cytoreductive surgery with perioperative intraperitoneal chemotherapy for peritoneal carcinomatosis of colorectal origin. Ann Surg Oncol 2009, 16(8):2152-2165.
9. Chua T.C., Robertson G., Liauw W., et al. Intraoperative hyperthermic intraperitoneal chemotherapy after cytoreductive surgery in ovarian cancer peritoneal carcinomatosis: systematic review of current results. J Cancer Res Clin Oncol 2009, 135:1637-1645.
10. Yan T.D., Black D., Sugarbaker P.H., et al. A systematic review and meta-analysis of the randomized controlled trials on adjuvant intraperitoneal chemotherapy for resectable gastric cancer. Ann Surg Oncol 2007, 14:2702-2713.
11. Rossi C.R., Casali P., Kusamura S., et al. The consensus statement on the locoregional treatment of abdominal sarcomatosis. J Surg Oncol 2008, 98:291-294.
12. Jacquet P., Jelinek J.S., Steves M.A., et al. Evaluation of computed tomography in patients with peritoneal carcinomatosis. Cancer 1993, 72(5):1631-1636.
13. de Bree E., Koops W., Kröger R., et al. Peritoneal carcinomatosis from colorectal or appendiceal origin: correlation of preoperative CT with intraoperative findings and evaluation of interobserver agreement. J Surg Oncol 2004, 86:64-73.
14. de Bree E., Koops W., Kröger R., et al. Preoperative computed tomography and selection of patients with colorectal peritoneal carcinomatosis for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Eur J Surg Oncol 2006, 32:65-71.
15. Dromain C., Leboulleux S., Auperin A., et al. Staging of peritoneal carcinomatosis: enhanced CT vsPET/CT. Abdom Imaging 2008, 33:87-93.
16. Yan T.D., Haveric N., Carmignani C.P., et al. Abdominal computed tomography scans in the selection of patients with malignant peritoneal mesothelioma for comprehensive treatment with cytoreductive surgery and perioperative intraperitoneal chemotherapy. Cancer 2005, 103:839-849.
17. Dowdy S.C., Mullany S.A., Brandt K.R., et al. The utility of computed tomography scans in predicting suboptimal cytoreductive surgery in women with advanced ovarian carcinoma. Cancer 2004, 101:346-352.
18. Funt S.A., Hricak H., Abu-Rustum N., et al. Role of CT in the management of recurrent ovarian cancer. AJR 2004, 182:393-398.
19. Oei T.N., Jagannathan J.P., Ramaiya N., et al. Peritoneal sarcomatosis versus peritoneal carcinomatosis: imaging findings at MDCT. JR Am J Roentgenol 2010, 195:229-235.
20. Turlakow A., Yeung H.W., Salmon A.S., Salmon A.S., et al. Peritoneal carcinomatosis: role of (18)F-FDG PET. J Nucl Med 2003, 44:1407-1412.
21. Suzuki A., Kawano T., Takahashi N., et al. Value of 18F-FDG PET in the detection of peritoneal carcinomatosis. Eur J Nucl Med Mol Imaging 2004, 31:1413-1420.
22. Pfannenberg C., Königsrainer I., Aschoff P., et al. (18)F-FDG-PET/CT to select patients with peritoneal carcinomatosis for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Ann Surg Oncol 2009, 16:1295-1303.
23. Passot G., Glehen O., Pellet O., et al. Pseudomyxoma peritonei: role of 18F-FDG PET in preoperative evaluation of pathological grade and potential for complete cytoreduction. Eur J Surg Oncol 2010, 36:315-323.
24. Pomel C., Appleyard T.L., Gouy S., et al. The role of laparoscopy to evaluate candidates for complete cytoreduction of peritoneal carcinomatosis and hyperthermic intraperitoneal chemotherapy. Eur J Surg Oncol 2005, 31:540-543.
25. Valle M., Garofalo A. Laparoscopic staging of peritoneal surface malignancies. Eur J Surg Oncol 2006, 32:625-627.
26. Portilla A.G., Shigeki K., Dario B., et al. The intraoperative staging systems in the management of peritoneal surface malignancy. J Surg Oncol 2008, 98:228-231.
27. Sugarbaker P.H. Peritonectomy procedures. Ann Surg 1995, 221:29-42.
28. González-Moreno S., Kusamura S., Baratti D., et al. Postoperative residual disease evaluation in the locoregional treatment of peritoneal surface malignancy. J Surg Oncol 2008, 98:237-241.
29. Kusamura S., Dominique E., Baratti D., et al. Drugs, carrier solutions and temperature in hyperthermic intraperitoneal chemotherapy. J Surg Oncol 2008, 98:247-252.
30. González-Bayón L., González-Moreno S., Ortega-Pérez G. Safety considerations for operating room personnel during hyperthermic intraoperative intraperitoneal chemotherapy perfusion. Eur J Surg Oncol 2006, 32:619-624.
31. Ortega-Deballon P, Facy O, Jambet S, et al. Which method to deliver hyperthermic intraperitoneal chemotherapy with oxaliplatin? An experimental comparison of open and closed techniques. Ann Surg Oncol, in press.
32. Sugarbaker P.H. An instrument to provide containment of intraoperative intraperitoneal chemotherapy with optimized distribution. J Surg Oncol 2005, 92:142-146.
33. Yonemura Y., Bandou E., Kinoshita K., et al. Effective therapy for peritoneal dissemination in gastric cancer. Surg Oncol Clin N Am 2003, 12:635-648.
34. Elias D., Antoun S., Goharin A., et al. Research on the best chemohyperthermia technique of treatment of peritoneal carcinomatosis after complete resection. Int J Surg Investig 2000, 1:431-439.
35. Glehen O., Osinsky D., Cotte E., et al. Intraperitoneal chemohyperthermia using a closed abdominal procedure and cytoreductive surgery for the treatment of peritoneal carcinomatosis: morbidity and mortality analysis of 216 consecutive procedures. Ann Surg Oncol 2003, 10:863-869.
36. Kusamura S., Younan R., Baratti D., et al. Cytoreductive surgery followed by intraperitoneal hyperthermic perfusion: analysis of morbidity and mortality in 209 peritoneal surface malignancies treated with closed abdomen technique. Cancer 2006, 106:1144-1153.
37. Elias D., Bonnay M., Puizillou J.M., Antoun S., Demirdjian S., El O.A., et al. Heated intra-operative intraperitoneal oxaliplatin after complete resection of peritoneal carcinomatosis: pharmacokinetics and tissue distribution. Ann Oncol. 2002, 13:267-272.
38. Sugarbaker P.H., Mora J.T., Carmignani P., et al. Update on chemotherapeutic agents utilized for perioperative intraperitoneal chemotherapy. Oncologist 2005, 10:112-122.
39. Park B.J., Alexander H.R., Libutti S.K., et al. Treatment of primary peritoneal mesothelioma by continuous hyperthermic peritoneal perfusion (CHPP). Ann Surg Oncol 1999, 6:582-590.
40. Steller M.A., Egorin M.J., Trimble E.L., et al. A pilot phase I trial of continuous hyperthermic peritoneal perfusion with high-dose carboplatin as primary treatment of patients with small-volume residual ovarian cancer. Cancer Chemother Pharmacol 1999, 43:106-114.
41. Elias D., Bonnay M., Puizillou J.M., et al. Heated intra-operative intraperitoneal oxaliplatin after complete resection of peritoneal carcinomatosis: pharmacokinetics and tissue distribution. Ann Oncol 2002, 13:267-272.
42. van Ruth S., Verwaal V.J., Zoetmulder F.A. Pharmacokinetics of intraperitoneal mitomycin C. Surg Oncol Clin N Am 2003, 12:771-780.
43. Yonemura Y., Fujimura T., Nishimura G., et al. Effects of intraoperative chemohyperthermia in patients with gastric cancer with peritoneal dissemination. Surgery 1996, 119:437-444.
44. Rossi C.R., Foletto M., Mocellin S., et al. Hyperthermic intraoperative intraperitoneal chemotherapy with cisplatin and doxorubicin in patients who undergo cytoreductive surgery for peritoneal carcinomatosis and sarcomatosis: phase I study. Cancer 2002, 94:492-499.
45. Elias D., Matsuhisa T., Sideris L., et al. Heated intra-operative intraperitoneal oxaliplatin plus irinotecan after complete resection of peritoneal carcinomatosis: pharmacokinetics, tissue distribution and tolerance. Ann Oncol 2004, 15:1558-1565.
46. Nicoletto M.O., Padrini R., Galeotti F., et al. Pharmacokinetics of intraperitoneal hyperthermic perfusion with mitoxantrone in ovarian cancer. Cancer Chemother Pharmacol 2000, 45:457-462.
47. de Bree E., Rosing H., Beijnen J.H., Romanos J., et al. Pharmacokinetic study of docetaxel in intraoperative hyperthermic i.p. chemotherapy for ovarian cancer. Anticancer Drugs 2003, 14:103-110.
48. de Bree E., Rosing H., Filis D., Romanos J., Melisssourgaki M., Daskalakis M., et al. Cytoreductive surgery and intraoperative hyperthermic intraperitoneal chemotherapy with paclitaxel: a clinical and pharmacokinetic study. Ann Surg Oncol 2008, 15:1183-1192.
49. Sugarbaker P.H., Stuart O.A. Pharmacokinetic and phase II study of heated intraoperative intraperitoneal melphalan. Cancer Chemother Pharmacol 2007, 59:151-155.
50. Chua T.C., Yan T.D., Saxena A., et al. Should the treatment of peritoneal carcinomatosis by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy still be regarded as a highly morbid procedure?: a systematic review of morbidity and mortality. Ann Surg 2009, 249:900-907.
51. Smeenk R.M., Verwaal V.J., Zoetmulder F.A. Learning curve of combined modality treatment in peritoneal surface disease. Br J Surg 2007, 94:1408-1414.
52. Yan T.D., Links M., Fransi S., et al. Learning curve for cytoreductive surgery and perioperative intraperitoneal chemotherapy for peritoneal surface malignancy - A journey to becoming a Nationally Funded Peritonectomy Center. Ann Surg Oncol 2007, 14:2270-2280.
53. Kusamura S., O'Dwyer S.T., Baratti D., et al. Technical aspects of cytoreductive surgery. J Surg Oncol 2008, 98:232-236.
54. Younan R., Kusamura S., Baratti D., et al. Bowel complications in 203 cases of peritoneal surface malignancies treated with peritonectomy and closed-technique intraperitoneal hyperthermic perfusion. Ann Surg Oncol 2005, 12:910-918.
55. Hansson J., Graf W., Påhlman L., et al. Postoperative adverse events and long-term survival after cytoreductive surgery and intraperitoneal chemotherapy. Eur J Surg Oncol 2009, 35:202-208.
56. Stephens A.D., Alderman R., Chang D., et al. Morbidity and mortality analysis of 200 treatments with cytoreductive surgery and hyperthermic intraoperative intraperitoneal chemotherapy using the coliseum technique. Ann Surg Oncol 1999, 6:790-796.
57. Glehen O., Osinsky D., Cotte E., et al. Intraperitoneal chemohyperthermia using a closed abdominal procedure and cytoreductive surgery for the treatment of peritoneal carcinomatosis: morbidity and mortality analysis of 216 consecutive procedures. Ann Surg Oncol 2003, 10:863-869.
58. Verwaal V.J., van Tinteren H., Ruth S.V., et al. Toxicity of cytoreductive surgery and hyperthermic intra-peritoneal chemotherapy. J Surg Oncol 2004 Feb, 85:61-67.
59. Kusamura S., Younan R., Baratti D., et al. Cytoreductive surgery followed by intraperitoneal hyperthermic perfusion: analysis of morbidity and mortality in 209 peritoneal surface malignancies treated with closed abdomen technique. Cancer 2006, 106:1144-1153.
60. Chua T.C., Saxena A., Schellekens J.F., et al. Morbidity and mortality outcomes of cytoreductive surgery and perioperative intraperitoneal chemotherapy at a single tertiary institution: towards a new perspective of this treatment. Ann Surg 2010, 251:101-106.
61. Saxena A., Yan T.D., Chua T.C., et al. Critical Assessment of Risk Factors for Complications After Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy for Pseudomyxoma Peritonei. Ann Surg Oncol 2010, 17:1291-1301.
62. Saxena A., Yan T.D., Morris D.L. Critical assessment of preoperative and operative risk factors for complications after iterative peritonectomy procedures. Eur J Surg Oncol 2010 Mar, 36(3):309-314.
63. Kusamura S., Baratti D., Younan R., et al. Impact of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy on systemic toxicity. Ann Surg Oncol 2007, 14:2550-2558.
64. Lambert L.A., Armstrong T.S., Lee J.J., et al. Incidence, risk factors, and impact of severe neutropenia after hyperthermic intraperitoneal mitomycin C. Ann Surg Oncol 2009, 16:2181-2187.
65. Elias D., Raynard B., Boige V., et al. Impact of the extent and duration of cytoreductive surgery on postoperative hematological toxicity after intraperitoneal chemohyperthermia for peritoneal carcinomatosis. J Surg Oncol 2005, 90:220-225.
66. Younan R., Kusamura S., Baratti D., et al. Morbidity, toxicity, and mortality classification systems in the local regional treatment of peritoneal surface malignancy. J Surg Oncol 2008, 98:253-257.
67. Bloemendaal A.L., Verwaal V.J., Van Ruth S., et al. Conventional surgery and systemic chemotherapy for peritoneal carcinomatosis of colorectal origin: a prospective study. Eur J Surg Oncol 2005, 31:1145-1151.
68. Pilati P., Mocellin S., Rossi C.R., et al. Cytoreductive surgery combined with hyperthermic intraperitoneal intraoperative chemotherapy for peritoneal carcinomatosis arising from colon adenocarcinoma. Ann Surg Oncol 2003, 10:508-513.
69. Glehen O., Kwiatkowski F., Sugarbaker P.H., et al. Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: A multi-institutional study. J Clin Oncol 2004, 22:3284-3292.
70. Glehen O., Cotte E., Schreiber V., et al. Intraperitoneal chemohyperthermia and attempted cytoreductive surgery in patients with peritoneal carcinomatosis of colorectal origin. Br J Surg 2004, 91:747-754.
71. Verwaal V.J., van Ruth S., Witkamp A., et al. Long-term survival of peritoneal carcinomatosis of colorectal origin. Ann Surg Oncol 2005, 12:65-71.
72. Elias D., Lefevre J.H., Chevalier J., et al. Complete cytoreductive surgery plus intraperitoneal chemohyperthermia with oxaliplatin for peritoneal carcinomatosis of colorectal origin. J Clin Oncol 2009, 27:681-685.
73. Kianmanesh R., Scaringi S., Sabate J.M., et al. Iterative cytoreductive surgery associated with hyperthermic intraperitoneal chemotherapy for treatment of peritoneal carcinomatosis of colorectal origin with or without liver metastases. Ann Surg 2007, 245:597-603.
74. Shen P., Thai K., Stewart J.H., et al. Peritoneal surface disease from colorectal cancer: comparison with the hepatic metastases surgical paradigm in optimally resected patients. Ann Surg Oncol 2008, 15:3422-3432.
75. Yan T.D., Morris D.L. Cytoreductive surgery and perioperative intraperitoneal chemotherapy for isolated colorectal peritoneal carcinomatosis: experimental therapy or standard of care?. Ann Surg 2008, 248:829-835.
76. Elias D., Gilly F., Boutitie F., et al. Peritoneal colorectal carcinomatosis treated with surgery and perioperative intraperitoneal chemotherapy: retrospective analysis of 523 patients from a multicentric French study. J Clin Oncol 2010, 28:63-68.
77. Verwaal V.J., van Ruth S., De Bree E., et al. Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer. J Clin Oncol 2003, 21:3737-3743.
78. Verwaal V.J., Bruin S., Boot H., et al. 8-year follow-up of randomized trial: cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer. Ann Surg Oncol 2008, 15:2426-2432.
79. Esquivel J., Sticca R., Sugarbaker P., et al. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the management of peritoneal surface malignancies of colonic origin: a consensus statement. Society of surgical oncology. Ann Surg Oncol 2007, 14:128-133.
80. Falcone A., Ricci S., Brunetti I., et al. Phase III trial of infusional fluorouracil, leucovorin, oxaliplatin, and irinotecan (FOLFOXIRI) compared with infusional fluorouracil, leucovorin, and irinotecan (FOLFIRI) as first-line treatment for metastatic colorectal cancer: the Gruppo Oncologico Nord Ovest. J Clin Oncol 2007, 25:1670-1676.
81. Kallinowski B. Indications and effect on survival of standard chemotherapy in advanced colorectal cancer. Recent Results Cancer Res 2005, 165:245-249.
82. Hurwitz H., Fehrenbacher L., Novotny W., et al. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med 2004, 350:2335-2342.
83. Van Cutsem E., Köhne C.H., Hitre H., et al. Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer. N Engl J Med 2009, 360:1408-1417.
84. Dy G.K., Krook J.E., Green E.M., et al. Impact of complete response to chemotherapy on overall survival in advanced colorectal cancer: results from Intergroup N9741. J Clin Oncol 2007, 25:3469-3474.
85. Aoki T., Umekita N., Tanaka S., et al. Prognostic value of concomitant resection of extrahepatic disease in patients with liver metastases of colorectal origin. Surgery 2008 Jun, 143(6):706-714.
86. Elias D., Sideris L., Pocard M., et al. Results of R0 resection for colorectal liver metastases associated with extrahepatic disease. Ann Surg Oncol 2004, 11:274-280.
87. Elias D., Liberale G., Vernerey D., et al. Hepatic and extrahepatic colorectal metastases: when resectable, their localization does not matter, but their total number has a prognostic effect. Ann Surg Oncol 2005, 12:900-909.
88. Elias D., Benizri E., Pocard M., et al. Treatment of synchronous peritoneal carcinomatosis and liver metastases from colorectal cancer. Eur J Surg Oncol 2006, 32:632-636.
89. Varban O., Levine E.A., Stewart J.H., et al. Outcomes associated with cytoreductive surgery and intraperitoneal hyperthermic chemotherapy in colorectal cancer patients with peritoneal surface disease and hepatic metastases. Cancer 2009, 115:3427-3436.
90. Gertsch P. A historical perspective on colorectal liver metastases and peritoneal carcinomatosis: similar results, different treatments. Surg Oncol Clin N Am 2003, 12:531-541.
91. Elias D., Delperro J.R., Sideris L., et al. Treatment of peritoneal carcinomatosis from colorectal cancer: impact of complete cytoreductive surgery and difficulties in conducting randomized trials. Ann Surg Oncol 2004, 11:518-521.
92. Miner T.J., Shia J., Jaques D.P., et al. Long-term survival following treatment of pseudomyxoma peritonei: an analysis of surgical therapy. Ann Surg 2005, 241:300-308.
93. Gough D.B., Donohue J.H., Schutt A.J., et al. Pseudomyxoma peritonei. Long-term patient survival with an aggressive regional approach. Ann Surg 1994, 219:112-119.
94. Schomas D.A., Miller R.C., Donohue J.H., et al. Intraperitoneal treatment for peritoneal mucinous carcinomatosis of appendiceal origin after operative management: long-term follow-up of the Mayo Clinic experience. Ann Surg 2009, 249:588-595.
95. Güner Z., Schmidt U., Dahlke M.H., et al. Cytoreductive surgery and intraperitoneal chemotherapy for pseudomyxoma peritonei. Int J Colorectal Dis 2005, 20:155-160.
96. Loungnarath R., Causeret S., Bossard N., et al. Cytoreductive surgery with intraperitoneal chemohyperthermia for the treatment of pseudomyxoma peritonei: a prospective study. Dis Colon Rectum 2005, 48:1372-1379.
97. Smeenk R.M., Verwaal V.J., Antonini N., et al. Survival analysis of pseudomyxoma peritonei patients treated by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Ann Surg 2007, 245:104-109.
98. Stewart J.H., Shen P., Russell G.B., et al. Appendiceal neoplasms with peritoneal dissemination: outcomes after cytoreductive surgery and intraperitoneal hyperthermic chemotherapy. Ann Surg Oncol 2006, 13:624-634.
99. Murphy E.M., Sexton R., Moran B.J. Early results of surgery in 123 patients with pseudomyxoma peritonei from a perforated appendiceal neoplasm. Dis Colon Rectum 2007, 50:37-42.
100. Yan T.D., Bijelic L., Sugarbaker P.H. Critical analysis of treatment failure after complete cytoreductive surgery and perioperative intraperitoneal chemotherapy for peritoneal dissemination from appendiceal mucinous neoplasms. Ann Surg Oncol 2007, 14:2289-2299.
101. Elias D., Honoré C., Ciuchendéa R., et al. Peritoneal pseudomyxoma: results of a systematic policy of complete cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Br J Surg 2008 Sep, 95(9):1164-1171.
102. Omohwo C., Nieroda C.A., Studeman K.D., et al. Complete cytoreduction offers longterm survival in patients with peritoneal carcinomatosis from appendiceal tumors of unfavorable histology. J Am Coll Surg 2009, 209:308-312.
103. Marcotte E., Sideris L., Drolet P., et al. Hyperthermic intraperitoneal chemotherapy with oxaliplatin for peritoneal carcinomatosis arising from appendix: preliminary results of a survival analysis. Ann Surg Oncol 2008, 15:2701-2708.
104. Elias D., Gilly F., Quenet F., et al. Association Française de Chirurgie. Pseudomyxoma peritonei: a French multicentric study of 301 patients treated with cytoreductive surgery and intraperitoneal chemotherapy. Eur J Surg Oncol 2010, 36:456-462.
105. Baratti D., Kusamura S., Nonaka D., et al. Pseudomyxoma peritonei: biological features are the dominant prognostic determinants after complete cytoreduction and hyperthermic intraperitoneal chemotherapy. Ann Surg 2009, 249:243-249.
106. Chua T.C., Yan T.D., Smigielski M.E., et al. Long-term survival in patients with pseudomyxoma peritonei treated with cytoreductive surgery and perioperative intraperitoneal chemotherapy: 10 years of experience from a single institution. Ann Surg Oncol 2009, 16:1903-1911.
107. Cioppa T., Vaira M., Bing C., et al. Cytoreduction and hyperthermic intraperitoneal chemotherapy in the treatment of peritonealcarcinomatosis from pseudomyxoma peritonei. World J Gastroenterol 2008, 14:6817-6823.
108. Sugarbaker P.H., Chang D. Results of treatment of 385 patients with peritoneal surface spread of appendiceal malignancy. Ann Surg Oncol 1999 Dec, 6(8):727-731.
109. Bijelic L., Yan T.D., Sugarbaker P.H. Treatment failure following complete cytoreductive surgery and perioperative intraperitoneal chemotherapy for peritoneal dissemination from colorectal or appendiceal mucinous neoplasms. J Surg Oncol 2008, 98:295-299.
110. Brouquet A., Goéré D., Lefèvre J.H., et al. The second procedure combining complete cytoreductive surgery and intraperitoneal chemotherapy for isolated peritoneal recurrence. postoperative course and long-term outcome. Ann Surg Oncol 2009, 16:2744-2751.
111. Glehen O., Mohamed F., Sugarbaker P.H. Incomplete cytoreduction in 174 patients with peritoneal carcinomatosis from appendiceal malignancy. Ann Surg 2004, 240:278-285.
112. Chua TC, Baker B, Yan TD, et al. Palliative effects of an incomplete cytoreduction combined with perioperative intraperitoneal chemotherapy. Am J Clin Oncol, in press.
113. Eltabbakh G.H., Piver M.S., Hempling R.E., et al. Clinical picture, response to therapy, and survival of women with diffuse malignant peritoneal mesothelioma. J Surg Oncol 1999, 70:6-12.
114. Brigand C., Monneuse O., Mohamed F., et al. Peritoneal mesothelioma treated by cytoreductive surgery and intraperitoneal hyperthermic chemotherapy: results of a prospective study. Ann Surg Oncol 2006, 13:405-412.
115. Feldman A.L., Libutti S.K., Pingpank J.F., et al. Analysis of factors associated with outcome in patients with malignant peritoneal mesothelioma undergoing surgical debulking and intraperitoneal chemotherapy. J Clin Oncol 2003, 21:4560-4567.
116. Yan T.D., Brun E.A., Cerruto CA., et al. Prognostic indicators for patients undergoing cytoreductive surgery and perioperative intraperitoneal chemotherapy for diffuse malignant peritoneal mesothelioma. Ann Surg Oncol 2007, 14:41-49.
117. Elias D., Bedard V., Bouzid T., et al. Malignant peritoneal mesothelioma: treatment with maximal cytoreductive surgery plus intraperitoneal chemotherapy. Gastroenterol Clin Biol 2007, 31:784-788.
118. Yano H., Moran B.J., Cecil T.D., et al. Cytoreductive surgery and intraperitoneal chemotherapy for peritoneal mesothelioma. Eur J Surg Oncol. 2009, 35:980-985.
119. Baratti D., Kusamura S., Cabras A.D., et al. Lymph node metastases in diffuse malignant peritoneal mesothelioma. Ann Surg Oncol 2010, 17:45-53.
120. Chua T.C., Yan T.D., Morris D.L. Outcomes of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal mesothelioma: the Australian experience. J Surg Oncol 2009, 99:109-113.
121. Blackham AU, Shen P, Stewart JH, et al. Cytoreductive surgery with intraperitoneal hyperthermic chemotherapy for malignant peritoneal mesothelioma: mitomycin versus cisplatin. Ann Surg Oncol, in press.
122. Yan T.D., Deraco M., Baratti D., et al. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for malignant peritoneal mesothelioma: multi-institutional experience. J Clin Oncol 2009, 27:6237-6242.
123. Yan T.D., Deraco M., Elias D., Glehen O., Levine E.A., Moran B.J., et al. Sugarbaker PH; Peritoneal Surface Oncology Group. A novel tumor-node-metastasis (TNM) staging system of diffuse malignant peritoneal mesothelioma using outcome analysis of a multi-institutional database. Cancer 2011, 117:1855-1863.
124. Deraco M., Bartlett D., Kusamura S., et al. Consensus statement on peritoneal mesothelioma. J Surg Oncol 2008, 98:268-272.
125. Bozzetti F., Yu W., Baratti D., et al. Locoregional treatment of peritoneal carcinomatosis from gastric cancer. J Surg Oncol 2008, 98:273-276.
126. Xu D.Z., Zhan Y.Q., Sun X.W., et al. Meta-analysis of intraperitoneal chemotherapy for gastric cancer. World J Gastroenterol 2004, 10:2727-2730.
127. Yan T.D., Black D., Sugarbaker P.H., et al. A systematic review and meta-analysis of the randomized controlled trials on adjuvant intraperitoneal chemotherapy for resectable gastric cancer. Ann Surg Oncol 2007, 14:2702-2713.
128. Yu W. A review of adjuvant therapy for resected primary gastric cancer with an update on Taegu's phase III trial with intraperitoneal chemotherapy. Eur J Surg Oncol 2006, 32:655-660.
129. Glehen O., Schreiber V., Cotte E., et al. Cytoreductive surgery and intraperitoneal chemohyperthermia for peritoneal carcinomatosis arising from gastric cancer. Arch Surg 2004, 139:20-26.
130. Hall J.J., Loggie B.W., Shen P., et al. Cytoreductive surgery with intraperitoneal hyperthermic chemotherapy for advanced gastric cancer. J Gastrointest Surg 2004, 8:454-463.
131. Yonemura Y., Kawamura T., Bandou E., et al. Treatment of peritoneal dissemination from gastric cancer by peritonectomy and chemohyperthermic peritoneal perfusion. Br J Surg 2005, 92:370-375.
132. Glehen O., Gilly F.N., Arvieux C., et al. Peritoneal carcinomatosis from gastric cancer: a multi-institutional study of 159 patients treated by cytoreductive surgery combined with perioperative intraperitoneal chemotherapy. Ann Surg Oncol 2010, 17:2370-2377.
133. Yang XJ, Huang CQ, Suo T, Mei LJ, Yang GL, Cheng FL, Zhou YF, et al. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy improves survival of patients with peritoneal carcinomatosis from gastric cancer: final results of a phase III randomized clinical trial. Ann Surg Oncol, in press.
134. Anaya D.A., Lahat G., Liu J., Xing Y., Cormier J.N., Pisters P.W., et al. Multifocality in retroperitoneal sarcoma: a prognostic factor critical to surgical decision-making. Ann Surg 2009 Jan, 249(1):137-142.
135. Bilimoria M.M., Holtz D.J., Mirza N.Q., et al. Tumor volume as a prognostic factor for sarcomatosis. Cancer 2002, 94:2441-2446.
136. Berthet B., Sugarbaker T.A., Chang D., et al. Quantitative methodologies for selection of patients with recurrent abdominopelvic sarcoma for treatment. Eur J Cancer 1999, 35:413-419.
137. Eilber F.C., Rosen G., Forscher C., et al. Recurrent gastrointestinal stromal sarcomas. Surg Oncol 2000, 9:71-75.
138. Bonvalot S., Cavalcanti A., Le Péchoux C., et al. Randomized trial of cytoreduction followed by intraperitoneal chemotherapy versus cytoreduction alone in patients with peritoneal sarcomatosis. Eur J Surg Oncol 2005, 31:917-923.
139. Rossi C.R., Deraco M., De Simone M., et al. Hyperthermic intraperitoneal intraoperative chemotherapy after cytoreductive surgery for the treatment of abdominal sarcomatosis: clinical outcome and prognostic factors in 60 consecutive patients. Cancer 2004, 100:1943-1950.
140. Baratti D., Pennacchioli E., Kusamura S., Fiore M., Balestra M.R., Colombo C., et al. Peritoneal sarcomatosis: is there a subset of patients who may benefit from cytoreductive surgery and hyperthermic intraperitoneal chemotherapy?. Ann Surg Oncol 2010 Dec, 17(12):3220-3228.
141. Ozols R.F. Treatment goals in ovarian cancer. Int J Gynecol Cancer 2005, 15(1):3-11.
142. Cannistra S.A. Cancer of the ovary. N Engl J Med 2004, 351:2519-2529.
143. Trimble E.L., Thompson S., Christian M.C., et al. Intraperitoneal chemotherapy for women with epithelial ovarian cancer. Oncologist 2008, 13:403-409.
144. Walker J.L., Armstrong D.K., Huang H.Q., et al. Intraperitoneal catheter outcomes in a phase III trial of intravenous versus intraperitoneal chemotherapy in optimal stage III ovarian and primary peritoneal cancer: a gynecologic oncology group study. J Clin Oncol 2006, 100:27-32.
145. Armstrong D.K., Bundy B., Wenzel L., et al. Intraperitoneal cisplatin and paclitaxel in ovarian cancer. N Engl J Med 2006, 354:34-43.
146. Helm C.W., Bristow R.E., Kusamura S., et al. Hyperthermic intraperitoneal chemotherapy with and without cytoreductive surgery for epithelial ovarian cancer. J Surg Oncol 2008, 98:283-290.
147. Piso P., Dahlke M.H., Loss M., et al. Cytoreductive surgery, hyperthermic intraperitoneal chemotherapy in peritoneal carcinomatosis from ovarian cancer. World J Surg Oncol 2004, 2:21.
148. Look M., Chang D., Sugarbaker P.H. Long-term results of cytoreductive surgery for advanced and recurrent epithelial ovarian cancers and papillary serous carcinoma of the peritoneum. Int J Gynecol Cancer 2004, 14:35-41.
149. Reichman T.W., Cracchiolo B., Sama J., et al. Cytoreductive surgery and intraoperative hyperthermic chemoperfusion for advanced ovarian carcinoma. J Surg Oncol 2005, 90:51-56.
150. Rufián S., Muñoz-Casares F.C., Briceño J., et al. Radical surgery-peritonectomy and intraoperative intraperitoneal chemotherapy for the treatment of peritoneal carcinomatosis in recurrent or primary ovarian cancer. J Surg Oncol 2006, 94:316-324.
151. Di Giorgio A., Naticchioni E., Biacchi D., et al. Cytoreductive surgery (peritonectomy procedures) combined with hyperthermic intraperitoneal chemotherapy (HIPEC) in the treatment of diffuse peritoneal carcinomatosis from ovarian cancer. Cancer 2008, 113:315-325.
152. Pavlov M.J., Kovacevic P.A., Ceranic M.S., et al. Cytoreductive surgery and modified heated intraoperative intraperitoneal chemotherapy (HIPEC) for advanced and recurrent ovarian cancer - 12-year single center experience. Eur J Surg Oncol 2009, 35:1186-1191.
153. Helm C.W., Richard S.D., Pan J., et al. Hyperthermic intraperitoneal chemotherapy in ovarian cancer: first report of the HYPER-O registry. Int J Gynecol Cancer 2010, 20:61-69.
154. Ryu K.S., Kim J.H., Ko H.S., et al. Effects of intraperitoneal hyperthermic chemotherapy in ovarian cancer. Gynecol Oncol 2004, 94:325-332.
155. Bae J.H., Lee J.M., Ryu K.S., et al. Treatment of ovarian cancer with paclitaxel- or carboplatin-based intraperitoneal hyperthermic chemotherapy during secondary surgery. Gynecol Oncol 2007, 106:193-200.
156. Guardiola E., Delroeux D., Heyd B., et al. Intra-operative intra-peritoneal chemotherapy with cisplatin in patients with peritoneal carcinomatosis of ovarian cancer. World J Surg Oncol 2009, 7:14.
157. Markman M., Liu P.Y., Wilczynski S., et al. Phase III randomized trial of 12 versus 3 months of maintenance paclitaxel in patients with advanced ovarian cancer after complete response to platinum and paclitaxel-based chemotherapy: a southwest oncology group and gynecologic oncology group trial. J Clin Oncol 2003, 21(13):2460-2465.
158. Piccart M.J., Floquet A., Scarfone G., et al. Intraperitoneal cisplatin versus no further treatment: 8-year results of EORTC 55875, a randomized phase III study in ovarian cancer patients with a pathologically complete remission after platinum-based intravenous chemotherapy. Int J Gynecol Cancer 2003, 13(Suppl 2):196-203.
159. Barakat R.R., Sabbatini P., Bhaskaran D., et al. Intraperitoneal chemotherapy for ovarian carcinoma: results of long-term follow-up. J Clin Oncol 2002, 20:694-698.
160. Tournigand C., Louvet C., Molitor J.L., et al. Long-term survival with consolidation intraperitoneal chemotherapy for patients with advanced ovarian cancer with pathological complete remission. Gynecol Oncol 2003, 91:341-345.
161. Gori J., Castaño R., Toziano M. Intraperitoneal hyperthermic chemotherapy in ovarian cancer. Int J Gynecol Cancer 2005, 15:233-239.
162. Kim J.H., Lee J.M., Ryu K.S., et al. Consolidation hyperthermic intraperitoneal chemotherapy using paclitaxel in patients with epithelial ovarian cancer. J Surg Oncol 2010, 101:149-155.
163. The ICON A.G.O. Collaborators. Paclitaxel plus platinum-based chemotherapy versus conventional platinum-based chemotherapy in women with relapsed ovarian cancer: the ICON4/AGO-OVAR-2.2 trial. Lancet 2003, 361:2099-2106.
164. Salani R., Santillan A., Zahurak M.L., Bristow R.E., et al. Secondary cytoreductive surgery for localized, recurrent epithelial ovarian cancer: analysis of prognostic factors and survival outcome. Cancer 2007, 109:685-691.
165. Bristow R.E., Puri I., Chi D.S. Cytoreductive surgery for recurrent ovarian cancer. Gynecol Oncol 2009, 112:265-274.
166. Deraco M., Rossi C.R., Pennacchioli E., et al. Cytoreductive surgery followed by intraperitoneal hyperthermic perfusion in the treatment of recurrent epithelial ovarian cancer: a phase II clinical study. Tumori 2001, 87:120-126.
167. de Bree E., Romanos J., Michalakis J., et al. Intraoperative hyperthermic intraperitoneal chemotherapy with docetaxel as second-line treatment for peritoneal carcinomatosis of gynaecological origin. Anticancer Res 2003, 23:3019-3027.
168. Zanon C., Clara R., Chiappino I., et al. Cytoreductive surgery and intraperitoneal chemohyperthermia for recurrent peritoneal carcinomatosis from ovarian cancer. World J Surg 2004, 28:1040-1045.
169. Raspagliesi F., Kusamura S., Campos Torres J.C., et al. Cytoreduction combined with intraperitoneal hyperthermic perfusion chemotherapy in advanced/recurrent ovarian cancer patients: The experience of National Cancer Institute of Milan. Eur J Surg Oncol 2006, 32:671-675.
170. Helm C.W., Randall-Whitis L., Martin R.S., et al. Hyperthermic intraperitoneal chemotherapy in conjunction with surgery for the treatment of recurrent ovarian carcinoma. Gynecol Oncol 2007, 105:90-96.
171. Cotte E., Glehen O., Mohamed F., et al. Cytoreductive surgery and intraperitoneal chemo-hyperthermia for chemo-resistant and recurrent advanced epithelial ovarian cancer: prospective study of 81 patients. World J Surg 2007, 31:1813-1820.
172. Fagotti A., Paris I., Grimolizzi F., et al. Secondary cytoreduction plus oxaliplatin-based HIPEC in platinum-sensitive recurrent ovarian cancer patients: a pilot study. Gynecol Oncol 2009, 113:335-340.
173. Ceelen WP, Van Nieuwenhove Y, Van Belle S, et al. Cytoreduction and hyperthermic intraperitoneal chemoperfusion in women with heavily pretreated recurrent ovarian cancer. Ann Surg Oncol, in press.